The CMA has cleared Linergy’s completed acquisition of Ulster Farm By-Products. This follows its provisional decision to clear the merger in November 2015. Click here.

The CMA is consulting on whether to make an Article 9 request to the European Commission to refer McKesson’s proposed acquisition of the united drug division and other associated businesses of UDG Healthcare to the CMA. Click here.